Friday, December 12, 2025 | 10:27 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Cipla gains as Cipla Medpro deal gets shareholders' approval

The move would help Cipla to integrate its marketing or front-end arm in South Africa.

Image

SI Reporter Mumbai
Cipla is trading higher by 3% to Rs 422 after the pharmaceutical company said the shareholders of Cipla Medpro South Africa have approved the takeover offer of company.

On February 28, 2013, Cipla had made a cash offer to acquire 100% shareholding of Cipla Medpro, and its shareholders have approved the takeover offer from Cipla at 10 Rand per share.

The move would help Cipla to integrate its marketing or front-end arm in South Africa with its manufacturing, regulatory and research units, they had added. Over 90% of Cipla Medpro’s supplies are from Cipla.

The stock opened at Rs 411 and hit a low of Rs 409 in early morning trades on BSE. A combined 1.32 million shares changed hands on the counter till early noon deals on BSE and NSE.
 
 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 16 2013 | 11:31 AM IST

Explore News